A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 77,494 shares of BMY stock, worth $4.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
77,494
Previous 77,276 0.28%
Holding current value
$4.4 Million
Previous $3.21 Million 24.96%
% of portfolio
0.04%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$39.66 - $51.75 $8,645 - $11,281
218 Added 0.28%
77,494 $4.01 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $67,338 - $88,652
-1,673 Reduced 2.12%
77,276 $3.21 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $2.65 Million - $3 Million
-55,214 Reduced 41.15%
78,949 $4.28 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $3.71 Million - $4.43 Million
-76,610 Reduced 36.35%
134,163 $6.88 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $5.61 Million - $6.27 Million
-96,878 Reduced 31.49%
210,773 $12.2 Million
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $3.8 Million - $4.21 Million
59,567 Added 24.01%
307,651 $19.7 Million
Q1 2023

May 10, 2023

SELL
$65.71 - $74.53 $6.9 Million - $7.82 Million
-104,932 Reduced 29.72%
248,084 $17.2 Million
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $1.41 Million - $1.67 Million
-20,543 Reduced 5.5%
353,016 $25.4 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $207,699 - $123 Million
-1,597,689 Reduced 81.05%
373,559 $26.6 Million
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $30.9 Million - $34.1 Million
-425,827 Reduced 17.76%
1,971,248 $152 Million
Q1 2022

May 10, 2022

BUY
$61.48 - $73.72 $1.62 Million - $1.95 Million
26,426 Added 1.11%
2,397,075 $175 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $127 Million - $148 Million
2,370,649 New
2,370,649 $148 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.